Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prophylaxis of Venous Thromboembolism”

286 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 286 results

Large-scale testing (Phase 3)Study completedNCT00951574
What this trial is testing

Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium)

Who this might be right for
Advanced CancerMetastatic Cancer
Italfarmaco 1,166
Large-scale testing (Phase 3)Study completedNCT00168818
What this trial is testing

Dabigatran Etexilate in Extended Venous Thromboembolism (VTE) Prevention After Hip Replacement Surgery

Who this might be right for
ThromboembolismArthroplasty, Replacement, Hip
Boehringer Ingelheim 3,494
Testing effectiveness (Phase 2)Study completedNCT02170701
What this trial is testing

BIBR 1048 in the Prevention of Venous Thromboembolism in Patients Undergoing Primary Elective Total Hip Replacement Surgery

Who this might be right for
Venous Thromboembolism
Boehringer Ingelheim 289
Post-approval studies (Phase 4)WithdrawnNCT03081169
What this trial is testing

Timing of VTE Prophylaxis in TBI

Who this might be right for
TBI (Traumatic Brain Injury)VTE (Venous Thromboembolism)
Loyola University
Testing effectiveness (Phase 2)Study completedNCT00408239
What this trial is testing

Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement

Who this might be right for
Thromboembolism
Astellas Pharma Inc 367
Not applicableStudy completedNCT00846807
What this trial is testing

Pradaxa (Dabigatran Etexilate 220 mg/q.d. in the General Population After Hip or Knee Replacement Surgery

Who this might be right for
Arthroplasty, ReplacementThromboembolism
Boehringer Ingelheim 5,476
Large-scale testing (Phase 3)Study completedNCT01206972
What this trial is testing

Dose-confirmatory Bridging Study in Total Knee Replacement

Who this might be right for
Venous Thromboembolism
Bayer 302
Not applicableWithdrawnNCT05536791
What this trial is testing

A Study in Europe Based on Medical Records That Looks at the Safety of Dabigatran in Children Below 2 Years of Age Who Have Had a Blood Clot and Are at Risk of Developing Another Blood Clot

Who this might be right for
Venous Thromboembolism
Boehringer Ingelheim
Post-approval studies (Phase 4)Study completedNCT04447378
What this trial is testing

Safety of Fondaparinux as Post Partum Thromboprophylaxis

Who this might be right for
Thromboembolism in the Puerperium
National University of Malaysia 60
Not applicableUnknownNCT01413464
What this trial is testing

The Risk of Venous Clotting in Patients After Renal Transplant

Who this might be right for
Venous ThrombosisEnd Stage Renal Failure With Renal TransplantDeep Vein Thrombosis+1 more
St. Joseph's Healthcare Hamilton 120
Large-scale testing (Phase 3)Study completedNCT00740987
What this trial is testing

Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)

Who this might be right for
No High Risk of Hemorrhage
University Hospital, Brest 621
Not applicableActive Not RecruitingNCT06193863
What this trial is testing

An Observational Study to Learn More About How Safe Rivaroxaban is And How Well it Works in Children With Congenital Heart Disease Who Had a Heart Surgery Called the Fontan Procedure

Who this might be right for
Prevention of Venous ThromboembolismCongenital Heart DiseaseFontan Procedure+1 more
Bayer 61
Post-approval studies (Phase 4)Not Yet RecruitingNCT07469488
What this trial is testing

A Clinical Trial on the Outcomes of Comprehensive Enhanced Prophylaxis Management (CEPM) in Chinese Patients With EGFR-Mutated Advanced NSCLC Receiving Amivantamab-Based Regimens

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)VTE (Venous Thromboembolism)Rash Due to Epidermal Growth Factor Receptor Inhibitors+1 more
Shanghai Pulmonary Hospital, Shanghai, China 122
Large-scale testing (Phase 3)Looking for participantsNCT07213778
What this trial is testing

REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants

Who this might be right for
Symptomatic Venous Thromboembolism (VTE)
Regeneron Pharmaceuticals 2,000
Testing effectiveness (Phase 2)Study completedNCT03522259
What this trial is testing

Rivaroxaban as Thrombosis Prophylaxis in Bariatric Surgery

Who this might be right for
Bariatric Surgery
Insel Gruppe AG, University Hospital Bern 272
Large-scale testing (Phase 3)Study completedNCT01583218
What this trial is testing

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Who this might be right for
Venous Thromboembolism (VTE)
Portola Pharmaceuticals 7,513
Large-scale testing (Phase 3)UnknownNCT00881088
What this trial is testing

Prophylaxis of Thromboembolic Complications Trial: Thromboprophylaxis Needed in Below Knee Plaster Cast Immobilization for Ankle and Foot Fractures

Who this might be right for
Deep Vein ThrombosisPulmonary Embolism
Red Cross Hospital Beverwijk 669
Not applicableUnknownNCT05347550
What this trial is testing

Examining the Benefit of Graduated Compression Stockings in the Prevention of vEnous Thromboembolism in Low-risk Surgical Patients

Who this might be right for
Venous Thromboembolism
Imperial College London 21,472
Post-approval studies (Phase 4)Study completedNCT04352439
What this trial is testing

Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy

Who this might be right for
Venous ThromboembolismOvarian Cancer
Duke University 19
Large-scale testing (Phase 3)Study completedNCT02815670
What this trial is testing

Reversal Dabigatran Anticoagulant Effect With Idarucizumab

Who this might be right for
Hemorrhage
Boehringer Ingelheim 1
Next Page